Research programme: macrolide antibacterials - Macrolide Pharmaceuticals

Drug Profile

Research programme: macrolide antibacterials - Macrolide Pharmaceuticals

Alternative Names: Antibacterials - Macrolide Pharmaceuticals; Antibiotics - Macrolide Pharmaceuticals; Macrolide antibiotics - Macrolide Pharmaceuticals

Latest Information Update: 30 Apr 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Macrolide Pharmaceuticals
  • Class Antibacterials; Macrolides; Small molecules
  • Mechanism of Action Protein 50S ribosomal subunit inhibitors; Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Bacterial infections

Most Recent Events

  • 04 Mar 2015 Macrolide Pharmaceuticals in-licenses synthesis technology from Harvard's Office of Technology Development
  • 04 Mar 2015 Early research in Bacterial infections in USA (IV)
  • 04 Mar 2015 Early research in Bacterial infections in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top